Pfizer and BioNTech Ask Federal Regulators to Authorize Booster Shot For 18 and Older | Healthcare Innovation

Posted on November 18, 2021 by Design in Design Innovation | 0 Comments

dreamstime_xxl_208751246.618c361d3e381.png

On Nov. 9, Pfizer and BioNTech asked federal regulators to authorize their coronavirus booster shot for individuals 18 and older, citing results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety